FDA issues Emergency Use Authorization for potential COVID-19 treatment, updates antibody test policy

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last email update on April 29, 2020 include:

Coronavirus (COVID-19) Updates:

• May 5, 2020: Daily Roundup: FDA actions on warning letters, generic drug approvals, and more
• May 4, 2020: FDA Voices: Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy
• April 30, 2020: FDA Includes Ventilator Developed by NASA in Ventilator Emergency Use Authorization
• April 29, 2020: Consumer Update: Tips on Good Nutrition and Using the Updated Nutrition Facts Label During the Coronavirus Pandemic
• April 29, 2020: From the Department of Justice, with FDA: Court Orders Halt to Sale of Silver Product fraudulently Touted as COVID-19 Cure
• More Daily Roundups (Monday - Friday) - Go to www.fda.gov/coronavirus, and select Daily Roundup (Type of Information) under Latest COVID-19 Information From the FDA